Pancreatic Cyst clinical trials
The registry lists 97 studies for Pancreatic Cyst across more than 10 countries. 37 are recruiting or about to start. 56 of them are mainly about Pancreatic Cyst (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30. Counting its narrower condition Pancreatic Pseudocyst too: 126 studies, 47 open.
Get an email when these change. Save the Pancreatic Cyst studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Mayo Clinic (5) · Massachusetts General Hospital (3) · Orlando Health, Inc. (3) · Johns Hopkins University (3) · University of Pittsburgh (2) · Umeå University (2) · University of California, Irvine (2) · IRCCS San Raffaele (2)
What is being tested here
Drugs under test in Pancreatic Cyst studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 8, phase 3 first
- Dec 2026Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? · Phase 3 · Case Comprehensive Cancer Center
- Nov 2026Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas · H. Lee Moffitt Cancer Center and Research Institute
- Dec 2026Artificial Intelligence in Endoscopic Ultrasound · Orlando Health, Inc.
- Feb 2027Tumour Regulatory Molecules in Early Pancreatic Cancer Detection · Hull University Teaching Hospitals NHS Trust
- Mar 2027Radiology Registry on Pancreatic Malignancies · IRCCS San Raffaele
- Apr 2027Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features · Chinese University of Hong Kong
- Jun 2027Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Jul 2027The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics · H. Lee Moffitt Cancer Center and Research Institute
Who these studies take
Of the 33 Pancreatic Cyst studies recruiting now, 25 (76%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (6%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (21%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (3%) | 1 (3%) |
| 18 | 31 (94%) | 31 (94%) |
| 30 | 33 (100%) | 33 (100%) |
| 40 | 33 (100%) | 33 (100%) |
| 50 | 33 (100%) | 33 (100%) |
| 65 | 33 (100%) | 33 (100%) |
| 75 | 33 (100%) | 33 (100%) |
| 85 | 33 (100%) | 33 (100%) |
Across all 97 studies, recruiting or not: 2% stop at 75 or younger and 1% at 65; 8% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Pancreatic Cyst studies take
Of 17 interventional studies with no phase under Pancreatic Cyst, half reached primary completion within 58 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 58 mo18–64 · 17 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 97. Browse all 97 → or search them.
- Pancreatic Cancer Early Detection ConsortiumRecruitingNCT0497005612 countries
- Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst FeaturesRecruitingNCT05334836Not applicable1 country
- EUS Examination Using EndoSound Vision System vs. Standard EchoendoscopeRecruitingNCT06340620Not applicable1 country
- Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic LesionsRecruitingNCT034921511 country
- Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate ResectionRecruitingNCT06320990Phase 11 country
- Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the PancreasNot yet recruitingNCT07843147
- Radiology Registry on Pancreatic MalignanciesRecruitingNCT057141111 country
- UCSF PANC Cyst RegistryRecruitingNCT042916511 country
- Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?RecruitingNCT05720338Phase 31 country
- Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous NeoplasmsRecruitingNCT063057281 country
- Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic CystsRecruitingNCT077672271 country
- A Study of Blood Based Biomarkers for Pancreas AdenocarcinomaRecruitingNCT033347082 countries
- The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)Enrolling by invitationNCT062767641 country
- A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease MonitoringRecruitingNCT077009921 country
- Tumour Regulatory Molecules in Early Pancreatic Cancer DetectionRecruitingNCT035367931 country
- Molecular Detection of Advanced Neoplasia in Pancreatic CystsRecruitingNCT03855800Not applicable1 country
- In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary CancersRecruitingNCT072063551 country
- Pancreas Registry and High Risk RegistryRecruitingNCT027754611 country
- Blood Markers of Early Pancreas CancerRecruitingNCT035686301 country
- PROMs After PancreatectomyRecruitingNCT071732571 country
- Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)RecruitingNCT06939023Not applicable1 country
- Artificial Intelligence in Endoscopic UltrasoundRecruitingNCT065645711 country
- Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas CancerRecruitingNCT032608421 country
- Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic AdenocarcinomaRecruitingNCT068671721 country
- Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the PancreasRecruitingNCT067067001 country
- Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps BiopsiesRecruitingNCT04404101Not applicable1 country
- Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic CancerRecruitingNCT051177231 country
- Quebec Pancreas Cancer StudyRecruitingNCT041042301 country
- Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic CystsRecruitingNCT05572788Not applicable1 country
- Genomic Profiling of Pancreatic Cystic TumorsNot yet recruitingNCT061959041 country
- Contrast Enhanced Endoscopic Ultrasound in Pancreas LesionsRecruitingNCT04324294Phase 11 country
- PAncreatic Disease Cohort of TOuLouseRecruitingNCT058244031 country
- Improving Pancreatic Cancer Care by the Use of Computational Science and TechnologyRecruitingNCT060550101 country
- Pancreatic Cyst Fluid Glucose: New Armamentarium in the Diagnosis of Mucinous Pancreatic Cystic LesionNot yet recruitingNCT05962723
- Contrast EUS of the PancreasRecruitingNCT02863770Not applicable1 country
- Confirmation of Association Between Cystic Fluid Analysis With Pancreatic Cystic LesionsRecruitingNCT054972711 country
- Prognostic Factors in Periampullary Tumors and CystsRecruitingNCT051558781 country
- Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical ResectionSuspendedNCT05873699Phase 11 country
- Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the PancreasActive, not recruitingNCT042755571 country
- The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel TherapeuticsActive, not recruitingNCT056925961 country
- Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective RegistryActive, not recruitingNCT071363241 country
- CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic CystsTerminatedNCT03085004Phase 31 country
- Early Detection of Pancreatic Cystic NeoplasmsCompletedNCT021104981 country
- The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts StudyCompletedNCT012021361 country
- Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT043069391 country
- Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary TumorsCompletedNCT04400357Not applicable1 country
- Laparotomy, Laparoscopy, da Vinci SystemCompletedNCT070344951 country
- EUS-guided Ablation of Pancreatic Cyst NeoplasmsCompletedNCT024221471 country
- Prevalence and Consequences of Hyperlactemia Following Pancreatic SurgeryCompletedNCT065891021 country
- Comparison Between Dual Energy/Subtraction CT With MRI for the Identification of Predictors of Malignancy in Cystic Pancreatic LesionsCompletedNCT03320733Not applicable1 country